A randomized control trial to evaluate the safety and feasibility of mono polar transurethral resection of prostate without post-operative urethral catheter traction in benign prostatic hyperplasia patients in a teritary care institute

Thisstudy is a randomized, double blind, parallel group, clinical trial to evaluatethe safety and feasibility of Monopolar Transurethral resection of prostatewithout postoperative urinary catheter traction. The gold standardsurgical management of Benign prostatic hyperplasia is transurethral resectionof prostate. An electrified wire loop is used to remove the part ofthe prostate between the bladder neck and the verumontanum up to thedepth of the surgical capsule. Incomplete hemostasis during the operation makespost-surgical bleeding one of the major drawbacks of transurethral resection ofprostate.Traction with a urethral catheter can decrease   bleeding after transurethral resection ofprostate. There is no standard protocol for the post operative management ofpatients with intraoperatively achieved hemostasis. Patients can be eithergiven traction with a urethral catheter or can avoid traction. With carefulcoagulation of venous and arterial bleeding, hemostasis can be achieved, thusavoiding the need for traction after the surgery. Also, traction results inincreased pain and analgesic consumption in patients.  In this study, we will evaluate the need fortraction if hemostasis can be secured intraoperatively, which will help todecrease the morbidity associated with traction. This will be achieved bycomparing the pain score and post operative blood loss of patients with urethralcatheter traction and without urethral catheter traction.